Last updated: February 15, 2024
Sponsor: Eysz, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Seizure Disorders (Pediatric)
Epilepsy (Pediatric)
Seizure Disorders
Treatment
Eysz Hyperventilation Recorder
Clinical Study ID
NCT06093490
1R43NS129363
1R43NS129363
Ages 4-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- typical absence seizure during use of the Eysz Hyperventilation Recorder or Control
Exclusion
Exclusion Criteria:
- Other seizure type besides typical absence seizure during use of the EyszHyperventilation Recorder
- subclinical seizure activity
- inability to participate with study procedures
- contraindications to hyperventilation including history of subarachnoid hemorrhage,sickle cell anemia, recent cerebrovascular accident or myocardial infarction,significant cardiopulmonary disease, active asthma, known aneurysm, known moyamoyadisease, or pregnancy.
- People who have a history of generalized tonic clonic convulsions (GTCs) provoked byhyperventilation
Study Design
Total Participants: 75
Treatment Group(s): 1
Primary Treatment: Eysz Hyperventilation Recorder
Phase:
Study Start date:
December 01, 2023
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Cincinnati Children's Hospital
Cincinnati, Ohio 045229
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.